Hemispherian AS logo

Hemispherian AS

Hemispherian is a biotechnology company developing new treatments for the most aggressive types of cancer.

10 employees · est. 2015 · Oslo, Norway

VS
Tagworks Pharmaceuticals logo

Tagworks Pharmaceuticals

Pioneer of Click-to-Release chemistry; designing more effective and safer systemic therapies

47 employees · est. 2011 · Nijmegen, The Netherlands

Tagworks Pharmaceuticals is the older company (2015 vs 2011); Tagworks Pharmaceuticals is the larger of the two.

Side-by-Side Comparison

Hemispherian AS Tagworks Pharmaceuticals
Founded
2015 2011 older
Headquarters
Oslo, Norway Nijmegen, The Netherlands
Employees
10 47 larger
Industry
Biotechnology, Health Care Biotechnology, Health Care, Pharmaceutical
Funding Stage
Grant Series A
Total Funding
$84.80M $65.00M
Funding Rounds
9 2
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Cancer Treatment, Glioblastoma Multiforme, Drug Development, Life Expectancy Improvement, Patient Comfort, Survival Rates, Aggressive Cancer, Oncology, Innovation, Clinical Research, Precision Medicine Precision Therapy, Cancer Treatment, Antibody-drug Conjugate, Immunomodulators, Radioimmunotherapies, Systemic Therapies, TAG72, Click-cleavable Therapies, Click-to-release Chemistry, Oncology, Drug Development, Therapeutic Index, Patent Estate, Precision Medicine
Website
hemispherian.com tagworkspharma.com
Hemispherian AS logo

About Hemispherian AS

Hemispherian AS is a biotechnology company based in Norway, founded in 2015. Their mission is to develop new treatments for the most aggressive types of cancer, with a focus on creating a new drug to treat Glioblastoma Multiforme (GBM). They aim to significantly increase life expectancy for patients...

Tagworks Pharmaceuticals logo

About Tagworks Pharmaceuticals

Tagworks Pharmaceuticals is a precision therapy company, leveraging its technology platform to develop a new standard of care for patients suffering from severe diseases including cancer. Founded in 2011 and headquartered in The Netherlands, Tagworks is pioneering the Click-to-Release approach, prot...

We will tell you when either one moves

BounceWatch watches Hemispherian AS and Tagworks Pharmaceuticals for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Hemispherian AS and Tagworks Pharmaceutica... — by email.

Frequently Asked Questions

Hemispherian AS — Hemispherian is a biotechnology company developing new treatments for the most aggressive types of cancer.. Tagworks Pharmaceuticals — Pioneer of Click-to-Release chemistry; designing more effective and safer systemic therapies. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Hemispherian AS has raised $84.80M while Tagworks Pharmaceuticals has raised $65.00M.
Hemispherian AS and Tagworks Pharmaceuticals operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Hemispherian AS with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Hemispherian AS on 11 Sep 2024, and Tagworks Pharmaceuticals on 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes